Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | BCL6 |
Upstream (Parents) |
---|
(<<) ACTB → BCL6 |
(<<) ATN1 → BCL6 |
(<<) CDH22 → BCL6 |
(<<) DAZAP2 → BCL6 |
(<<) DHX9 → BCL6 |
(<<) ELOVL1 → BCL6 |
(<<) MAT2A → BCL6 |
(<<) PRPF4B → BCL6 |
(<<) PTPN11 → BCL6 |
(<<) RAC1 → BCL6 |
(<<) RARG → BCL6 |
(<<) RAVER1 → BCL6 |
(<<) RCAN1 → BCL6 |
(<<) ROCK2 → BCL6 |
(<<) SEMA5B → BCL6 |
(<<) SLC34A3 → BCL6 |
(<<) YWHAE → BCL6 |
Downstream (Children) |
---|
BCL6 → CASP9 (>>) |
BCL6 → DVL3 (>>) |
BCL6 → ELF2 (>>) |
BCL6 → GNB5 (>>) |
BCL6 → HDAC8 (>>) |
BCL6 → INF2 (>>) |
BCL6 → MMP14 (>>) |
BCL6 → NOTCH2 (>>) |
BCL6 → PLA2G3 (>>) |
BCL6 → PPP1R3B (>>) |
BCL6 → RASSF1 (>>) |
BCL6 → TIMM13 (>>) |
BCL6 → TMSB10 (>>) |
BCL6 → ZNF205 (>>) |